Chaperonin 10 immunosuppression
AssigneeCBio Limited
InventorsGeoffrey R. Hill, Tatjana Banovic, Halle Morton, Alice Christina Cavanagh
Life of this patent
Estimating the term…
Abstract
The invention is directed to the use of cpnl0 in transplantation and particularly to treatment and/or prevention of graft versus host disease. The invention provides a method of administration of cpn10 to a donor and/or recipient animal or cells, tissues or organs derived from the donor, although in a particularly advantageous form treatment of both the donor and recipient animal. The method may further include the administration to the donor and/or recipient animal at least one other immunosuppressive agent to prevent or alleviate graft versus host disease.
Claims2
A pharmaceutical composition comprising:
- a pharmaceutically-effective amount of cpn10 comprising the amino acid sequence set forth in FIG. 1 (SEQ ID NO:1), and
- a pharmaceutically-acceptable carrier, excipient or diluent.
An isolated polypeptide comprising the amino acid sequence set forth in FIG. 1 (SEQ ID NO:1).
Dependencies are inferred from the claim text.